Serological responses to rotavirus NSP2 following administration of RV3-BB human neonatal rotavirus vaccine

References

• Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, Ngwira B, Victor JC, Gillard PH, Cheuvart BB, Han HH, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med. 2010;362:289–98. doi:10.1056/NEJMoa0904797. PMID:20107214.
   PubMed Web of Science ®Google Scholar
• Bar-Zeev N, Kapanda L, Tate JE, Jere KC, Iturriza-Gomara M, Nakagomi O, Mwansambo C, Costello A, Parashar UD, Heyderman RS, et al. Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and case-control study. Lancet Infect Dis. 2015;15:422–8. doi:10.1016/S1473-3099(14)71060-6. PMID:25638521.
   PubMed Web of Science ®Google Scholar
• Kirkwood CD, Ma LF, Carey ME, Steele AD. The rotavirus vaccine development pipeline. Vaccine. 2017; pii: S0264-410X(17)30410-3. doi:10.1016/j.vaccine.2017.03.076. [Epub ahead of print]
   Web of Science ®Google Scholar
• Bishop RF, Barnes GL, Cipriani E, Lund JS. Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children. N Engl J Med. 1983;309:72–6. doi:10.1056/NEJM198307143090203. PMID:6304516.
   PubMed Web of Science ®Google Scholar
• Bines JE, Danchin M, Jackson P, Handley A, Watts E, Lee KJ, West A, Cowley D, Chen MY, Barnes GL, et al. Safety and immunogenicity of RV3-BB human neonatal rotavirus vaccine administered at birth or in infancy: a randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2015;15:1389–97. doi:10.1016/S1473-3099(15)00227-3. PMID:26318715.
   PubMed Web of Science ®Google Scholar
• Grimwood K, Lund JC, Coulson BS, Hudson IL, Bishop RF, Barnes GL. Comparison of serum and mucosal antibody responses following severe acute rotavirus gastroenteritis in young children. J Clin Microbiol. 1988;26:732–8. PMID:2835391.
   PubMed Web of Science ®Google Scholar
• Svensson L, Sheshberadaran H, Vene S, Norrby E, Grandien M, Wadell G. Serum antibody responses to individual viral polypeptides in human rotavirus infections. J Gen Virol. 1987;68 (Pt 3):643–51. doi:10.1099/0022-1317-68-3-643. PMID:3029295.
   PubMed Web of Science ®Google Scholar
• Ushijima H, Honma H, Ohnoda H, Mukoyama J, Oyanagi H, Araki K, Shinozaki T, Morikawa S, Kitamura T. Detection of anti-rotavirus IgG, IgM, and IgA antibodies in healthy subjects, rotavirus infections, and immunodeficiencies by immunoblotting. J Med Virol. 1989;27:13–8. doi:10.1002/jmv.1890270104. PMID:2537874.
   PubMed Web of Science ®Google Scholar
• Colomina J, Gil MT, Codoner P, Buesa J. Viral proteins VP2, VP6, and NSP2 are strongly precipitated by serum and fecal antibodies from children with rotavirus symptomatic infection. J Med Virol. 1998;56:58–65. doi:10.1002/(SICI)1096-9071(199809)56:1%3c58::AID-JMV10%3e3.0.CO;2-S. PMID:9700634.
   PubMed Web of Science ®Google Scholar
• Richardson SC, Bishop RF. Homotypic serum antibody responses to rotavirus proteins following primary infection of young children with serotype 1 rotavirus. J Clin Microbiol. 1990;28:1891–7. PMID:2172292.
   PubMed Web of Science ®Google Scholar
• Kirkwood CD, Boniface K, Richardson S, Taraporewala ZF, Patton JT, Bishop RF. Non-structural protein NSP2 induces heterotypic antibody responses during primary rotavirus infection and reinfection in children. J Med Virol. 2008;80:1090–8. doi:10.1002/jmv.21160. PMID:18428132.
   PubMed Web of Science ®Google Scholar
• Vizzi E, Calvino E, Gonzalez R, Perez-Schael I, Ciarlet M, Kang G, Estes MK, Liprandi F, Ludert JE. Evaluation of serum antibody responses against the rotavirus nonstructural protein NSP4 in children after rhesus rotavirus tetravalent vaccination or natural infection. Clin Diagn Lab Immunol. 2005;12:1157–63. PMID:16210477.
   PubMedGoogle Scholar
• Patel M, Glass RI, Jiang B, Santosham M, Lopman B, Parashar U. A systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacy. J Infect Dis. 2013;208:284–94. doi:10.1093/infdis/jit166. PMID:23596320.
   PubMed Web of Science ®Google Scholar
• Velazquez FR, Matson DO, Guerrero ML, Shults J, Calva JJ, Morrow AL, Glass RI, Pickering LK, Ruiz-Palacios GM. Serum antibody as a marker of protection against natural rotavirus infection and disease. J Infect Dis. 2000;182:1602–9. doi:10.1086/317619. PMID:11069230.
   PubMed Web of Science ®Google Scholar
• Angel J, Steele AD, Franco MA. Correlates of protection for rotavirus vaccines: Possible alternative trial endpoints, opportunities, and challenges. Hum Vaccin Immunother. 2014;10:3659–71. doi:10.4161/hv.34361.
   PubMed Web of Science ®Google Scholar
• Petrie BL, Greenberg HB, Graham DY, Estes MK. Ultrastructural localization of rotavirus antigens using colloidal gold. Virus Res. 1984;1:133–52. doi:10.1016/0168-1702(84)90069-8. PMID:6099654.
   PubMed Web of Science ®Google Scholar
• Taraporewala Z, Chen D, Patton JT. Multimers formed by the rotavirus nonstructural protein NSP2 bind to RNA and have nucleoside triphosphatase activity. J Virol. 1999;73:9934–43. PMID:10559306.
   PubMed Web of Science ®Google Scholar
• Donker NC, Foley M, Tamvakis DC, Bishop R, Kirkwood CD. Identification of an antibody-binding epitope on the rotavirus A non-structural protein NSP2 using phage display analysis. J Gen Virol. 2011;92:2374–82. doi:10.1099/vir.0.032599-0. PMID:21697352.
   PubMed Web of Science ®Google Scholar
• Moon SS, Groome MJ, Velasquez DE, Parashar UD, Jones S, Koen A, van Niekerk N, Jiang B, Madhi SA. Prevaccination Rotavirus Serum IgG and IgA Are Associated With Lower Immunogenicity of Live, Oral Human Rotavirus Vaccine in South African Infants. Clin Infect Dis. 2016;62:157–65. doi:10.1093/cid/civ828. PMID:26400993.
   PubMed Web of Science ®Google Scholar
• Appaiahgari MB, Glass R, Singh S, Taneja S, Rongsen-Chandola T, Bhandari N, Mishra S, Vrati S. Transplacental rotavirus IgG interferes with immune response to live oral rotavirus vaccine ORV-116E in Indian infants. Vaccine. 2014;32:651–6. doi:10.1016/j.vaccine.2013.12.017. PMID:24374502.
   PubMed Web of Science ®Google Scholar
• Delem A, Vesikari T. Detection of serum antibody responses to RIT 4237 rotavirus vaccine by ELISA and neutralization assays. J Med Virol. 1987;21:231–8. doi:10.1002/jmv.1890210306. PMID:3031200.
   PubMed Web of Science ®Google Scholar
• Chen MY, Kirkwood CD, Bines J, Cowley D, Pavlic D, Lee KJ, Orsini F, Watts E, Barnes G, Danchin M. Rotavirus specific maternal antibodies and immune response to RV3-BB neonatal rotavirus vaccine in New Zealand. Hum Vaccin Immunother. 2017;13:1126–35. doi:10.1080/21645515.2016.1274474. PMID:28059609.
   PubMed Web of Science ®Google Scholar
• Li Z, Baker ML, Jiang W, Estes MK, Prasad BV. Rotavirus architecture at subnanometer resolution. J Virol. 2009;83:1754–66. doi:10.1128/JVI.01855-08. PMID:19036817.
   PubMed Web of Science ®Google Scholar
• Danchin M, Kirkwood CD, Lee KJ, Bishop RF, Watts E, Justice FA, Clifford V, Cowley D, Buttery JP, Bines JE. Phase I trial of RV3-BB rotavirus vaccine: a human neonatal rotavirus vaccine. Vaccine. 2013;31:2610–6. doi:10.1016/j.vaccine.2013.04.008. PMID:23597719.
   PubMed Web of Science ®Google Scholar
• Cowley D, Boniface K, Bogdanovic-Sakran N, Kirkwood CD, Bines JE. Rotavirus shedding following administration of RV3-BB human neonatal rotavirus vaccine. Hum Vaccin Immunother. 2017;13:1908–15. Epub 2017 May 8. doi:10.1080/21645515.2017.1323591
   PubMed Web of Science ®Google Scholar
• Anderson EJ. Rotavirus vaccines: viral shedding and risk of transmission. Lancet Infect Dis. 2008;8:642–9. doi:10.1016/S1473-3099(08)70231-7. PMID:18922486.
   PubMed Web of Science ®Google Scholar